Literature DB >> 1706452

Nuclease-resistant polyadenylated RNAs of significant size are detected by PCR in highly purified Creutzfeldt-Jakob disease preparations.

A Akowitz1, T Sklaviadis, E E Manuelidis, L Manuelidis.   

Abstract

The molecular nature of the 'unconventional viruses' that cause slow, progressive brain deterioration is still poorly understood. As part of a reinvestigation of potential agent-specific nucleic acids, we developed a protocol for enriching agent-specific sequences. This protocol uses extensive micrococcal nuclease digestion followed by rate zonal sucrose sedimentation. Most of the infectivity in the gradient (84%) had a characteristic mean size of approximately 120S, and was resolved from 70% of a host glycoprotein (PrP) that can cosediment with infectivity. In infectious size fractions, nucleic acids were reduced approximately one million-fold with respect to starting brain homogenate, and specific purification of infectivity was approximately 100,000-fold with respect to nucleic acid. Using a novel polymerase chain reaction strategy, we were able to amplify RNA species in these fractions. Remarkably, host polyadenylated sequences of 1 to over 4 kb were detected in the nuclease-protected infectious fractions. These strategies set the stage for the identification of similar nucleic acids that may be specific for the CJD agent.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1706452     DOI: 10.1016/0882-4010(90)90038-r

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  15 in total

1.  A simplified recipe for prions.

Authors:  Kil Sun Lee; Byron Caughey
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-29       Impact factor: 11.205

2.  A specific population of abnormal prion protein aggregates is preferentially taken up by cells and disaggregated in a strain-dependent manner.

Authors:  Young Pyo Choi; Suzette A Priola
Journal:  J Virol       Date:  2013-08-21       Impact factor: 5.103

3.  Ultrastructural studies on scrapie prion protein crystals obtained from reverse micellar solutions.

Authors:  H Wille; S B Prusiner
Journal:  Biophys J       Date:  1999-02       Impact factor: 4.033

4.  Vaccination with an attenuated Creutzfeldt-Jakob disease strain prevents expression of a virulent agent.

Authors:  L Manuelidis
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-03       Impact factor: 11.205

5.  Nucleic acid binding proteins in highly purified Creutzfeldt-Jakob disease preparations.

Authors:  T Sklaviadis; A Akowitz; E E Manuelidis; L Manuelidis
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-15       Impact factor: 11.205

6.  Endogenous viral complexes with long RNA cosediment with the agent of Creutzfeldt-Jakob disease.

Authors:  A Akowitz; T Sklaviadis; L Manuelidis
Journal:  Nucleic Acids Res       Date:  1994-03-25       Impact factor: 16.971

7.  Microglial activation varies in different models of Creutzfeldt-Jakob disease.

Authors:  C A Baker; Z Y Lu; I Zaitsev; L Manuelidis
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

Review 8.  The intriguing prion disorders.

Authors:  K Abid; C Soto
Journal:  Cell Mol Life Sci       Date:  2006-10       Impact factor: 9.261

9.  A transmissible Creutzfeldt-Jakob disease-like agent is prevalent in the human population.

Authors:  E E Manuelidis; L Manuelidis
Journal:  Proc Natl Acad Sci U S A       Date:  1993-08-15       Impact factor: 11.205

10.  Viral particles are required for infection in neurodegenerative Creutzfeldt-Jakob disease.

Authors:  L Manuelidis; T Sklaviadis; A Akowitz; W Fritch
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-23       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.